We serve Chemical Name:1-methyl-3-methylidenepiperidin-2-one CAS:1690-73-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-methyl-3-methylidenepiperidin-2-one
CAS.NO:1690-73-9
Synonyms:2-Piperidinone,1-methyl-3-methylene;1-Methyl-3-methylen-2-piperidon;1-Methyl-3-methylen-piperidon-(2);1-methyl-3-methylenepiperidine-2-one;1-methyl-3-methylene-2-piperidone;1-methyl-3-methylene-piperidin-2-one;1-methyl-3-methylene-2-piperidinone
Molecular Formula:C7H11NO
Molecular Weight:125.16800
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:20.31000
Exact Mass:125.08400
LogP:0.73270
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-Piperidinone,1-methyl-3-methylene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-methyl-3-methylene-2-piperidinone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Methyl-3-methylen-2-piperidon Use and application,1-methyl-3-methylenepiperidine-2-one technical grade,usp/ep/jp grade.
Related News: MSD – known as Merck in the US and Canada – is jointly developing Verquvo with Bayer. While MSD hold the commercial rights to the heart failure med in the US, Bayer has the exclusive commercial rights in the rest of the world. spiro[1,3-dihydroquinazoline-2,4′-piperidine]-4-one hydrochloride manufacturers AstraZeneca’s deal, the largest struck last year, is all part of CEO Pascal Soriot’s mission to hit $40 billion in global sales by 2023. O-methyl-L-threonine suppliers Defining the deliverables of the project in advance helps CDMOs to work through a realistic timeline that can work mutually for both parties. N-(3-bromo-5-methylpyridin-2-yl)-8-methoxyquinoline-5-carboxamide vendor & factory The Company most recently announced plans to establish a dedicated laboratory space with Biosafety Level-3 (BSL-3) containment to handle testing of SARS-CoV-2 (the viral strain causing COVID-19) and other similar pathogens that cause human disease. ,The Company most recently announced plans to establish a dedicated laboratory space with Biosafety Level-3 (BSL-3) containment to handle testing of SARS-CoV-2 (the viral strain causing COVID-19) and other similar pathogens that cause human disease.
